Pulmonary Hypertension with Lung Disease

Brief description of study

Researchers at the University of Kentucky are conducting a study to investigate the safety and how well the inhaled investigational drug treprostinil works in people with pulmonary hypertension associated with lung disease. This study will look at your ability to exercise after taking the study drug.

You may be eligible to participate if you:
-Are 18 years of age or older;
-Do not have a history of drug abuse;
-Are able to walk for 6-minutes; and
-Do not have diabetes.

Participants will be compensated for your time.

For more information, please contact:
Ketan Buch, MD
kpbuch0@uky.edu
or
Research coordinator:
859-218-6740